Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.

In contrast, high lgals2 expression was associated with a good DFS, although the difference fell just short of the traditional definition of statistical significance (0.064).

also in 2 other papers